Socialize

RSS Feed

New $30 Million Funding Agreement Could Result In New Stroke Medicine


Toronto News, (PR) January 27, 2012

Capital Corp Merchant Banking websiteCapital Corp Merchant Banking has entered into a $ 30 million funding agreement with a major German Biopharmaceutical Group (the Client) to fund the production process, clinical trials, and full commercialization of a stroke therapeutic. This would be done through a combination of debt and equity.

Capital Corp Merchant Banking offers quality Merchant Banking services for a variety of projects worldwide. Capital Corp Merchant Banking has developed close working relationships with groups of Professionals: Specialists in Finance, Commercial Risks Insurance and Re-Insurance, International Accounting Firms and Law Firms, and the largest Valuation Firm in the world. Capital Corp Merchant Banking is solution-oriented and known for being the most flexible Funding Source on the Market in creating handcrafted investment structures to meet the needs of the different constituent groups in each individual transaction. Capital Corp Merchant Banking offers many services: Project Financing, Consulting, Due Diligence, Evaluation of a Business, Negotiating Services, Acquisitions, Investment Approach, and Presentation Reports as well.

A stroke happens when blood flow to a part of the brain stops. A stroke is sometimes called a brain attack. Ischemic stroke occurs when a blood vessel that supplies blood to the brain is blocked by a blood clot. This may happen in two ways: 1) a clot may for in an artery that is already very narrow, which is called a thrombotic stroke; and 2) a clot may break off from another place in the blood vessel of the brain or body and travel up to the brain, which is called cerebral embolism, or embolic stroke. Ischemic strokes may be caused by clogged arteries.

Stroke is the third leading cause of death in the United States, and approximately 795,000 people suffer a stroke each year, 140,000 of which result in death. Europe averages approximately 650,000 stroke deaths each year.

There are only a few hundred stroke neurology specialists practicing in Europe and the United States, and the number of stroke centers in both the U.S. and Europe number slightly above 1,600 combined. Stroke centers are presently certified to treat ischemic stroke.

The Clients theranostic offers the ability to rapidly take control of a 240 M market in the EU and expand it to 400-500M, and would similarly offer the same results in the U.S. market.

The method by which this project is to be funded is the brainchild of Mr Gilles Herard, Jr. Mr Herard is a seasoned Merchant Banker and has been in the banking industry for 38 years. He worked early in his career at the Toronto Dominion Bank (Canada) and later on joined Manufacturer Hanover (MH) of New York as Senior Credit Analyst. He eventually created his own Firm, Capital Corp Merchant Banking, where he syndicates and structures funding for top companies worldwide, all the while investing his own firms funds into the projects.

As the head of Capital Corp Merchant Banking, Mr Herard has become a leading figure in international middle-market project financing and engineers all funding structures for projects at Capital Corp. Mr Herard has received numerous awards for his work and other contributions including being appointed to the Presidential Business Commission, Honorary Co-Chairman of the Business Advisory Council, nominated as Executive of the Year by the internationally acclaimed National Registers Whos Who, and having received the Senatorial Medal of Freedom, among many others.

 

More Toronto Business News